Bis-indole derivatives, pharmaceutical compositions...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/209, 260/237

C07D 519/04 (2006.01) A61K 31/475 (2006.01)

Patent

CA 1278790

ABSTRACT The invention relates to novel bis-indole derivatives of the general formula. (I) Image (I) wherein R1 stands for a hydrogen atom or an acetyl group; R2 stands for a hydrogen atom; R3 means an ethyl group of .alpha.-position; or R2 and R3 together represent an oxygen bridge; R4 represents an ethyl or hydroxyl group of .beta.-position; and R5 stands for a hydrogen atom or a hydroxyl group; A represents a straight-chain C1-10 alkyl; a branched-chain C3-10 alkyl group; a C1-4 alkyl group containing in the omega position a hydroxyl, C2-5 alkanyloxy, carbamoyl or formylamino substituent; a benzyl group, a pyridyl group or a phenyl group; and X stands for a sulphur atom, or pharmaceutically acceptable acid addition salts and pharmaceutical preparations containing these compounds. Further on, the invention relates to a process for preparing these compounds and preparations. The compounds of the general formula (I) show a cytostatic activity with less toxicity than that of the known vinblastine-type bis-indole alkaloid drugs which are commercially available.

511394

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Bis-indole derivatives, pharmaceutical compositions... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bis-indole derivatives, pharmaceutical compositions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bis-indole derivatives, pharmaceutical compositions... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1312385

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.